SOURCE: Pacific Dynasty Consultants / Issues Investment Alert On (PINK:UYMG), (PINK:RAYS), (OTC:ACTC), (OTC:ADXS), (OTC:XDSL) Is announcing Investment Highlights on Unity Management Group Inc (PINK:UYMG), Raystream Inc (PINK:RAYS), Advanced Cell Technology Inc (OTC:ACTC), Advaxis Inc (OTC:ADXS)

Pompano Beach, Fla. (January 4, 2013)



Unity Management Group Inc (PINKSHEETS: UYMG) is currently trading at $0.0002 on a traded volume of 4.0 million shares. So far this year, the stock is up over 100%. The 52-week range for the stock is $0.0 and $0.01. Unity Management Group Inc is a management resource company, which provides management services that offer value and return, through its three subsidiary companies: Unity Capital Acquisitions, Unity Technologies Inc., and Unity Business Services. 

Will UYMG Move Higher After Today’s Sudden Selling Activities? Don’t Miss The Free Trend Analysis here


Raystream Inc (PINKSHEETS: RAYS) declined 12.50% to $0.0014 on a traded volume of 5.13 million shares. In the last one year, the stock is down over 99%. The 52-week range for the stock is $0.0 and $1.24. Raystream Inc is an encoding and transcoding service and technology company, engages in the provision of video compression services in the United States and internationally.

How Should Investors Trade RAYS After The Recent Momentum, Find Out Here


Advanced Cell Technology Inc (OTC: ACTC) is up marginally 0.66% to $0.0610 on a traded volume of 587k shares. Earlier, the Company announced the treatment of the fifth and sixth patients in the company’s European clinical trial for Stargardt’s Macular Dystrophy using retinal pigment epithelial cells derived from human embryonic stem cells, completing the second patient cohort. The patients were injected with 100,000 hESC-derived RPE cells as compared to 50,000 cells in the first cohort. The outpatient transplantation surgeries were performed successfully and the patients are recovering uneventfully. 

Get Free Special Trend Analysis On ACTC Here


Advaxis Inc (OTC: ADXS) augmented 7.58% to $0.0355 on a traded volume of 793k shares. The Company appointed Daniel J. O'Connor to the position of Senior Vice President, Chief Legal and Business Development Officer. Advaxis is a clinical-stage biotechnology company developing the next generation of immunotherapies for cancer and infectious diseases.   

Get Free Special Trend Analysis On ADXS Here 


mPhase Technologies Inc (OTC: XDSL) surged up 5.26% to $0.0020 on a traded volume of 1.26 million shares. The Company has been issued patent number 8,344,543 from the U.S. Patent & Trademark Office. The invention generally relates to a handheld, powered device containing at least one power module having at least one battery, wherein the power module is removable and separately connects to each of the load modules.

Get Free Special Trend Analysis On XDSL Here 


About has a finger on the pulse of many sectors including renewable energy, oil, pharma, mining, finance, and healthcare. Our in depth research and analysis of NASDAQ, OTCBB, Pink Sheets, and NYSE has yielded considerable gains for our subscribers.

Our to-the-minute reports and alerts coupled with breaking news, analysis, investment strategies, and FREE subscription email services contribute to our role as one of the leading investor relations marketing firms.


The assembled information disseminated by is for information purposes only, and is neither a solicitation to buy nor an offer to sell securities. does expect that investors will buy and sell securities based on information assembled and presented in PLEASE always do your own due diligence, and consult your financial advisor.





Pacific Dynasty Consultants Inc.

2637 E Atlantic Blvd #22611 Pompano Beach, FL 33062